Your browser doesn't support javascript.
loading
Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project.
Wu, Zeni; Petrick, Jessica L; Florio, Andrea A; Guillemette, Chantal; Beane Freeman, Laura E; Buring, Julie E; Bradwin, Gary; Caron, Patrick; Chen, Yu; Eliassen, A Heather; Engel, Lawrence S; Freedman, Neal D; Gaziano, J Michael; Giovannuci, Edward L; Hofmann, Jonathan N; Huang, Wen-Yi; Kirsh, Victoria A; Kitahara, Cari M; Koshiol, Jill; Lee, I-Min; Liao, Linda M; Newton, Christina C; Palmer, Julie R; Purdue, Mark P; Rohan, Thomas E; Rosenberg, Lynn; Sesso, Howard D; Sinha, Rashmi; Stampfer, Meir J; Um, Caroline Y; Van Den Eeden, Stephen K; Visvanathan, Kala; Wactawski-Wende, Jean; Zeleniuch-Jacquotte, Anne; Zhang, Xuehong; Graubard, Barry I; Campbell, Peter T; McGlynn, Katherine A.
Afiliação
  • Wu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Petrick JL; Slone Epidemiology Center, Boston University, Boston, MA, USA.
  • Florio AA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Guillemette C; Pharmacogenomics Laboratory, Centre Hospitalier Universitaire de Québec-(CHU de Québec) Research Center-Université Laval, Québec, QC, Canada.
  • Beane Freeman LE; Faculty of Pharmacy and Cancer Research Center, Laval University, Québec, QC, Canada.
  • Buring JE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Bradwin G; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Caron P; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Chen Y; Clinical and Epidemiologic Research Laboratory, Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Eliassen AH; Pharmacogenomics Laboratory, Centre Hospitalier Universitaire de Québec-(CHU de Québec) Research Center-Université Laval, Québec, QC, Canada.
  • Engel LS; Department of Population Health, New York University School of Medicine, New York, NY, USA.
  • Freedman ND; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Gaziano JM; Department of Nutrition, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Giovannuci EL; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hofmann JN; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
  • Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Kirsh VA; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kitahara CM; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Koshiol J; Department of Nutrition, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Lee IM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Liao LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Newton CC; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Palmer JR; Epidemiology Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Rohan TE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Rosenberg L; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Sesso HD; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Sinha R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Stampfer MJ; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
  • Um CY; Slone Epidemiology Center, Boston University, Boston, MA, USA.
  • Van Den Eeden SK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Visvanathan K; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, NY, USA.
  • Wactawski-Wende J; Slone Epidemiology Center, Boston University, Boston, MA, USA.
  • Zeleniuch-Jacquotte A; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Zhang X; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Graubard BI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Campbell PT; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • McGlynn KA; Department of Nutrition, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
JHEP Rep ; 5(7): 100742, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37425211
ABSTRACT
Background &

Aims:

Incidence rates of liver cancer in most populations are two to three times higher among men than women. The higher rates among men have led to the suggestion that androgens are related to increased risk whereas oestrogens are related to decreased risk. This hypothesis was investigated in the present study via a nested case-control analysis of pre-diagnostic sex steroid hormone levels among men in five US cohorts.

Methods:

Concentrations of sex steroid hormones and sex hormone-binding globulin were quantitated using gas chromatography-mass spectrometry and a competitive electrochemiluminescence immunoassay, respectively. Multivariable conditional logistic regression was used to calculate odds ratios (ORs) and 95% CIs for associations between hormones and liver cancer among 275 men who subsequently developed liver cancer and 768 comparison men.

Results:

Higher concentrations of total testosterone (OR per one-unit increase in log2 = 1.77, 95% CI = 1.38-2.29), dihydrotestosterone (OR = 1.76, 95% CI = 1.21-2.57), oestrone (OR = 1.74, 95% CI = 1.08-2.79), total oestradiol (OR = 1.58, 95% CI=1.22-20.05), and sex hormone-binding globulin (OR = 1.63, 95% CI = 1.27-2.11) were associated with increased risk. Higher concentrations of dehydroepiandrosterone (DHEA), however, were associated with a 53% decreased risk (OR = 0.47, 95% CI = 0.33-0.68).

Conclusions:

Higher concentrations of both androgens (testosterone, dihydrotestosterone) and their aromatised oestrogenic metabolites (oestrone, oestradiol) were observed among men who subsequently developed liver cancer compared with men who did not. As DHEA is an adrenal precursor of both androgens and oestrogens, these results may suggest that a lower capacity to convert DHEA to androgens, and their subsequent conversion to oestrogens, confers a lower risk of liver cancer, whereas a greater capacity to convert DHEA confers a greater risk. Impact and implications This study does not fully support the current hormone hypothesis as both androgen and oestrogen levels were associated with increased risk of liver cancer among men. The study also found that higher DHEA levels were associated with lower risk, thus suggesting the hypothesis that greater capacity to convert DHEA could be associated with increased liver cancer risk among men.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article